From: Major coagulation disorders and parameters in COVID-19 patients
Group | Name | Abbreviation | Dominant changes | References |
---|---|---|---|---|
Coagulation problems | Arterial thromboembolism | ATE | Blood clotting | |
Deep vein thrombosis | DVT | Blood clotting | ||
Disseminated intravascular coagulation/sepsis-induced coagulopathy | DIC/SIC | Blood clotting | ||
Pulmonary embolism | PE | Blood clotting | ||
Venous thromboembolism | VTE | Blood clotting | ||
Coagulation parameters | D-dimer | – | Increase | |
Factor VIII/Von Willebrand factor | FVIII/VWF | Increase | ||
Fibrinogen and Fibrin degradation products | FDP | Increase | ||
Lymphocyte count | – | Decrease | ||
Partial thromboplastin time/Prothrombin time | PTT/PT | Get longer | ||
Platelet count | – | Decrease | ||
Inflammatory markers | Antiphospholipid antibodies | aPL antibodies | Increase | |
C-reactive protein/procalcitonin | CRP/PCT | Increase | ||
Lactate dehydrogenase | LDH | Increase | ||
Neutrophil-to-lymphocyte ratio | NLR | Increase |